Control of cardiac pyruvate dehydrogenase activity in peroxisome proliferator-activated receptor-alpha transgenic mice
- PMID: 12663261
- DOI: 10.1152/ajpheart.00852.2002
Control of cardiac pyruvate dehydrogenase activity in peroxisome proliferator-activated receptor-alpha transgenic mice
Abstract
The pyruvate dehydrogenase enzyme complex (PDC) is rate limiting for glucose oxidation in the heart. Inhibition of PDC by end-product feedback and phosphorylation by pyruvate dehydrogenase kinase (PDK) operate in concert to inhibit PDC activity. Because the transcriptional regulator peroxisome proliferator-activated receptor (PPAR)-alpha increases PDK expression in some tissues, we examined what role PPAR-alpha has in regulating glucose oxidation in hearts from mice overexpressing PPAR-alpha (MHC-PPAR-alpha mice). Glucose oxidation rates were decreased in isolated working hearts from MHC-PPAR-alpha mice compared with wild-type littermates (428 +/- 113 vs. 771 +/- 63 nmol x g dry weight-1x min-1, respectively), which was accompanied by a parallel increase in fatty acid oxidation. However, there was no difference in PDC activity between MHC-PPAR-alpha and wild-type animals, even though the expression of the PDK isoform PDK1 was increased in MHC-PPAR-alpha mice. Glucose oxidation rates in both MHC-PPAR-alpha and wild-type mouse hearts were decreased after 48-h fasting (which increases PPAR-alpha expression) or by treatment of mice with the PPAR-alpha agonist WY-14,643 for 1 wk. Despite this, PDC activity in both animal groups was not altered. Taken together, these data suggest that glucose oxidation rates in the heart can be dramatically altered independent of PDK phosphorylation and inhibition of PDC by PDK. It also suggests that PPAR-alpha activation decreases glucose oxidation in hearts mainly by decreasing the flux of pyruvate through PDC due to negative feedback of PDC by fatty acid oxidation reaction products rather than by the phosphorylated state of the PDC complex.
Similar articles
-
Selective modification of pyruvate dehydrogenase kinase isoform expression in rat pancreatic islets elicited by starvation and activation of peroxisome proliferator-activated receptor-alpha: implications for glucose-stimulated insulin secretion.Diabetes. 2001 Dec;50(12):2729-36. doi: 10.2337/diabetes.50.12.2729. Diabetes. 2001. PMID: 11723055
-
PPAR alpha ligand protects during cisplatin-induced acute renal failure by preventing inhibition of renal FAO and PDC activity.Am J Physiol Renal Physiol. 2004 Mar;286(3):F572-80. doi: 10.1152/ajprenal.00190.2003. Epub 2003 Nov 11. Am J Physiol Renal Physiol. 2004. PMID: 14612380
-
Therapeutic potential of the mammalian pyruvate dehydrogenase kinases in the prevention of hyperglycaemia.Curr Drug Targets Immune Endocr Metabol Disord. 2002 Jul;2(2):151-65. Curr Drug Targets Immune Endocr Metabol Disord. 2002. PMID: 12476789 Review.
-
Role of peroxisome proliferator-activated receptor-alpha in the mechanism underlying changes in renal pyruvate dehydrogenase kinase isoform 4 protein expression in starvation and after refeeding.Arch Biochem Biophys. 2001 Nov 15;395(2):246-52. doi: 10.1006/abbi.2001.2586. Arch Biochem Biophys. 2001. PMID: 11697863
-
Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases.Arch Physiol Biochem. 2006 Jul;112(3):139-49. doi: 10.1080/13813450600935263. Arch Physiol Biochem. 2006. PMID: 17132539 Review.
Cited by
-
Validation of the in vivo assessment of pyruvate dehydrogenase activity using hyperpolarised 13C MRS.NMR Biomed. 2011 Feb;24(2):201-208. doi: 10.1002/nbm.1573. Epub 2010 Aug 26. NMR Biomed. 2011. PMID: 20799252 Free PMC article.
-
Adipose-Specific PPARα Knockout Mice Have Increased Lipogenesis by PASK-SREBP1 Signaling and a Polarity Shift to Inflammatory Macrophages in White Adipose Tissue.Cells. 2021 Dec 21;11(1):4. doi: 10.3390/cells11010004. Cells. 2021. PMID: 35011564 Free PMC article.
-
Dioxygen and Metabolism; Dangerous Liaisons in Cardiac Function and Disease.Front Physiol. 2017 Dec 12;8:1044. doi: 10.3389/fphys.2017.01044. eCollection 2017. Front Physiol. 2017. PMID: 29311974 Free PMC article. Review.
-
PPARdelta agonism inhibits skeletal muscle PDC activity, mitochondrial ATP production and force generation during prolonged contraction.J Physiol. 2009 Jan 15;587(1):231-9. doi: 10.1113/jphysiol.2008.164210. Epub 2008 Nov 10. J Physiol. 2009. PMID: 19001043 Free PMC article.
-
Metabolic dysfunction in diabetic cardiomyopathy.Heart Fail Rev. 2014 Jan;19(1):35-48. doi: 10.1007/s10741-013-9377-8. Heart Fail Rev. 2014. PMID: 23443849 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous